Tag Archives: PRAA

Top 10 Performing Stocks To Buy For 2018

March 16, 2017: Markets opened higher again Thursday but the uptick did not last longer. Within an hour shares had dropped and a brief turn higher was foiled quickly. The worst performing sectors for the day are utilities and healthcare, with financials showing the only decent gain. WTI crude oil for April delivery settled at $48.75 a barrel, down 0.2% on the day. April gold added 2.2% on the day to settle at $1,227.10. Equities were headed for a lower close shortly before the bell as the DJIA traded down 0.11% for the day, the S&P 500 traded down 0.22%, and the Nasdaq Composite traded down 0.02%.

The DJIA stock posting the largest daily percentage loss ahead of the close Thursday was E.I. du Pont de Nemours Inc. (NYSE: DD) which traded down 1.14% at $80.56. The stock’s 52-week range is $61.12 to $81.51. Volume was roughly 40% below the daily average of around 2.6 million shares. The company had no specific news.

Chevron Corp. (NYSE: CVX) traded down 1.00% at $107.79. The stock’s 52-week range is $92.25 to $119.00. Volume was about 10% below the daily average of around 6.3 million shares. The integrated oil & gas company had no specific news.

Top 10 Performing Stocks To Buy For 2018: Tobira Therapeutics, Inc.(TBRA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Allergan (NYSE: AGN) acquired Akarna Therapeutics global rights to AKN-083 for up-front payment of $50 million. This came just hours after Allergan bought Tobira Therapeutics (NASDAQ: TBRA) for upfront Payment of $28.35 share in cash, up to $49.84 per share in CVRs.

Top 10 Performing Stocks To Buy For 2018: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By George Budwell]

    Unfortunately for Clovis and its shareholders, though, Astra’s Lynparza is currently underpriority review with the FDA as a maintenance therapy in ovarian cancer, andTesaro’s (NASDAQ:TSRO)rival PARP inhibitor Zejula gained an early approval– along with afar broader label than Rubraca — just this week.

  • [By Ben Levisohn]

    Who has PARP? A poly ADP-ribose polymerase inhibitor (PARPi) kills cancer cells by interfering tumor DNA repair pathway with the potential to treat ovarian, breast and prostate cancer. Studies have shown that patients with BRCA mutations (BRCAmut) respond to PARPi. AstraZenecas (AZN) PARPi was approved in 2014 whileClovis Oncology (CLVS) and Tesaro (TSRO) both have positive Phase III data. Clovis licensed its PARPi from Pfizer (PFE) in 2011 and Tesaro licensed its PARPi from Merck (MRK) in 2012, after Sanofis (SNY) PARPi (later demonstrated that it cannot block PARP) failed in Phase III in early 2011.

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

  • [By Ben Levisohn]

    Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:

    Getty Images

    We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation. We were at ESMO this weekend, and we believe the big takeaway on Tesaro data is that it works broadly in all 2L ovarian populations and safety looks solid. We also think the robustness of this data bodes well from PRIMA and QUADRA but are maintaining our POS here. We have looked at our model and also adjusted durations in first-line. We think Tesaro remains one of the most attractive and de-risked cancer assets in our landscape and the company has been cited in major press sources as a takeout target (Bloomberg, Investor Business Daily).

    We think M&A remains in focus for Tesaro. Our M&A DCF valuations range from $122 to $157 by our model. We have also built models for other cancers like NSCLC, SCLC, prostate, and others where PARP might be impactful. We assume 0% POS for now but we conservatively see at least another $1B in sales from PARP expansion. Tesaro has been cited in the press as a potential M&A target and is a company we frequently hear mentioned as a target from our conversations. We think the demand for late stage oncology assets is high, especially in the PARP space given the potential for activity across a range of tumors. For a large Pharma player who already has an oncology salesforce and large R&D infrastructure we could see SG&A synergies of 50-75% and R&D synergies of 15-30%. In our base case TSRO P&L we model a tax rate of 30% so there could be synergies here as well. Two additional key swing factors which might be included in a CVR are how much expansion from PARP in other cancers and immuno-oncology…

    Ex M&A,

  • [By Ben Levisohn]

    Look out below! Shares of Tesaro (TSRO) have dropped more than 10% this afternoon after AstraZeneca (AZN) released stronger-than-expected Phase 3 trial data on a its ovarian cancer treatment.

    Agence France-Presse/Getty Images

    The Street’sAdam Feuerstein has the details on AstraZeneca’s strong data and its impact on Tesaro:

    AstraZeneca’s (AZN) PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo, according to results from a phase III study presented Tuesday.

    The strong benefit observed with Lynparza as ovarian cancer maintenance therapy exceeded investor expectations and bolsters AstraZeneca against a competing PARP inhibitor from Tesaro (TSRO).

    Feuerstein also notes that AstraZeneca’s data could be good newsClovis Oncology (CLVS), which also had a PARP inhibitor approved recently, if it means that its drug could work as well as Astra’s.

    In February, Leerink cut Tesaro, arguing that the rally in its shares due to a potential takeover had run too far. Will it still be a takeover target?

    Shares of Tesaro have dropped 14% to $148.01 at 3:28 p.m. today, while AstraZeneca has gained 1.1% to $30.41, and Clovis Oncology has jumped 9.8% to$66.55.

    UPDATE:Piper Jaffray’sSteven Breazzano andJoshua Schimmer note that the AstraZeneca data shows that PARPs are “more similar than different.” They explain:

    This afternoon AstraZeneca (covered by PJC analyst Richard Purkiss) reported the detailed results from the SOLO-2 maintenance study of Lynparza in 2L+ ovarian cancer. The detailed data highlights a PFS benefit of 14 months (investigator assessed, and primary endpoint) and 25 months (blinded central review) over placebo, and favorable hazard ratio of 0.30 and 0.25, respectively, confirming our view that the PARP’s are more similar than different. As such, we believe this provides a favorable readth

Top 10 Performing Stocks To Buy For 2018: Cardiome Pharma Corporation(CRME)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of CARDIOME PHARMA CORP (NASDAQ: CRME) were down 30 percent to $2.72 after the company issued U.S. regulatory update for BRINAVESS. The FDA advised Cardiome that the data package proposed is not sufficient to support re-submission of the BRINAVESS NDA.

  • [By Lisa Levin]

    Shares of CARDIOME PHARMA CORP (NASDAQ: CRME) were down 43 percent to $3.01. Cardiome priced 10 million shares at $3 per share.

    Seadrill Partners LLC (NYSE: SDLP) was down, falling around 30 percent to $4.09 as the company announced plans to reduce the quarterly cash distribution to $0.10 per unit from $0.25 per unit.

Top 10 Performing Stocks To Buy For 2018: Blackrock Global(BOE)

Advisors’ Opinion:

  • [By Robert Rapier]

    Whiting Petroleum (WLL) is one of Continental’s biggest competitors in the Bakken. Whiting is the second-largest oil producer in North Dakota, averaging 82,500 barrels of oil equivalent (BOE) of production in 2012, across more than 700,000 acres of leased land.

Top 10 Performing Stocks To Buy For 2018: Atara Biotherapeutics, Inc.(ATRA)

Advisors’ Opinion:

  • [By Chris Lange]

    Atara Biotherapeutics Inc. (NASDAQ: ATRA) shares surged on Friday after the firm announced that it received clearance from the U.S. Food and Drug Administration (FDA) to initiate two Phase 3 clinical studies. Specifically these mid-stage studies deal with tabelecleucel in patients with rituximab-refractory Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+PTLD).

Top 10 Performing Stocks To Buy For 2018: Clarke(t)

Advisors’ Opinion:

  • [By Jim Robertson]

    DirecTV is a direct broadcast satellite service provider and is a subsidiary of AT&T Inc (NYSE: T). Its satellite service, launched on June 17, 1994, transmits digital satellite television and audio to households in the United States, Latin America and the Caribbean withprimary competitorsbeing Dish Network and cable television providers. On July 24, 2015, after receiving approval from the FCC and United States Department of Justice, AT&T acquired DirecTV in a transaction valued at $48.5 billion. DirecTV would be paying$1.5 billion a year for the NFL Sunday Ticket.AT&T’s shares may have broken out of a downtrend:

  • [By Brian Feroldi, Dan Caplinger, Rich Duprey, Jason Hall, and Jordan Wathen]

    In order to point you in the right direction, we asked a team of Fools to highlight a dividend stock that they feel is a great stock for a beginner. Read on to see why they picked AT&T (NYSE:T),Apple (NASDAQ:AAPL),Anheuser-Busch InBev(NYSE:BUD), Mastercard(NYSE:MA), andJPMorgan Chase(NYSE:JPM).

  • [By Paul Ausick]

    AT&T Inc. (NYSE: T) dropped about 1.4% Tuesday to post a new 52-week low of $35.87 after closing Monday at $36.39. The 52-week high is $43.50. Volume was around 5.8 million shares traded, nearly 10 times the daily average of around 600,000. The company had no specific news.

  • [By Douglas A. McIntyre]

    At the other end of the iPhone 8 spectrum, wireless companies like AT&T Inc. (NYSE: T) probably will price the low-end version of the iPhone 8 below $40 a month, with 24-month contracts. This kind of price plan is a usual way for large wireless carriers to get and hold customers for long periods. Even if the carrier pays a lot for the smartphone, it presumably makes that back in monthly fees and on people who renew their subscriptions for a longer period.

  • [By Chris Lange]

    AT&T Inc.’s (NYSE: T) second-quarter results are scheduled for Tuesday. The consensus earnings estimate is $0.74 per share, on $39.82 billion in revenue. The shares were last seen at $36.51. The consensus price target is $40.27, and the 52-week trading range is $35.81 to $43.50.

Top 10 Performing Stocks To Buy For 2018: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews Nick Pinchuk, CEO of Snap-on (SNA) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By John Divine]

    Snap-on Incorporated (SNA) is my choice for the Best Stocks for 2016 competition. At a market cap of $10 billion, I doubt it will double over the next year, as some of the smaller companies in this competition might be able to.

    That said, Snap-on, which manufactures and markets hand tools and diagnostic equipment, is a rock-solid company with an attractive valuation and impressive growth. It goes for 22 times earnings, pays a consistent and modest dividend, and has been around since 1920.

    As cars get more tech-heavy and complicated, newer tools and better diagnostics will be needed — and that’s SNA’s bread ‘n’ butter. 

  • [By WWW.MONEYSHOW.COM]

    Snap-on (SNA)

    Snap-on, which is more than 100 years old, provides hand and power tools for individuals and professionals, including auto-shop tools and auto diagnostic equipment.

Top 10 Performing Stocks To Buy For 2018: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

Top 10 Performing Stocks To Buy For 2018: Tyson Foods Inc.(TSN)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

  • [By Peter Graham]

    A long term performance chart shows shares ofmid cap Sanderson Farms more than doubling in value while large cap Tyson Foods, Inc (NYSE: TSN)has more than tripled in value and mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) has quadrupled in value:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanderson Farms doubling in value while mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) and large cap Tyson Foods, Inc (NYSE: TSN) have been even better performers albeit shares are below their peaks and have been somewhat volatile:

Top 10 Performing Stocks To Buy For 2018: Oasis Petroleum Inc.(OAS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Oasis Petroleum Inc. (NYSE: OAS) were down 14 percent to $8.60 after the company reported a 32 million share common stock offering. The company announced Delaware Basin acquisition for $946 million and also raised its Q4 production guidance.

  • [By Jon C. Ogg]

    Oasis Petroleum Inc. (NYSE: OAS) rose a whopping 27.8% to $14.98, and the 33.2 million shares was about 2.5 times normal volume. Oasis Petroleum has a 52-week trading range of $3.40 to $15.02 and a consensus analyst price target of $14.54. The company has a total market cap of $3.5 billion.

  • [By Chris Lange]

    Oasis Petroleum Inc. (NYSE: OAS) shares slid on Tuesday after the company announced that it would be buying into the Delaware Basin. Analysts seemed to applaud this move, despite investors sending shares into the fire. Jefferies raised its price target to $14 from $13, and Morgan Stanley raised its target to $11 from $9. RBC has an Outperform rating and raised its target to $14 from $13, while SunTrust Robinson Humphrey downgraded it to Hold from Buy. Shares were down about 14% at $8.67, in a 52-week range of $6.69 to $16.73.

  • [By Paul Ausick]

    Oasis Petroleum Inc. (NYSE: OAS) is rated a Buy and the price target was lifted to $24. For 2017, the net loss estimate improved from a prior $0.27 per share to $0.23 per share. The 2018 EPS estimate rose from $0.62 to $0.64. Shares closed at $14.13 on Friday. The 52-week range is $5.93 to $14.35, and the consensus 12-month target is $17.87.

  • [By Craig Jones]

    Jon Najarian spoke on CNBC’s “Fast Money Halftime Report” about unusually high options activity in Oasis Petroleum Inc. (NYSE: OAS).

    Traders bought around 10,000 contracts of the June 10 calls in the first half of the trading session on Thursday. The trade is unusual because the average options volume in the name is a few hundred contracts. Najarian bought the calls and is planning to hold them for two weeks.

trading stocks online

Tech heavyweight Apple Inc. (NASDAQ:AAPL) is on the move, threatening to lift out of its two-month consolidation range as it coils up beneath its 50-day moving average. Shares have been languishing near $145, a level first reached back in May, after the so-called “FAANG” technology stocks got hit with selling pressure back in early June.

There is no specific catalyst for the rebound, merely the appearance of some “buy-the-dip” confidence after Federal Reserve Board Chair Janet Yellen wrapped up her two-day semi-annual testimony to Congress.

 

trading stocks online: DXP Enterprises Inc.(DXPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of DXP Enterprises Inc (NASDAQ: DXPE) were down 17 percent to $24.00. DXP Enterprises reported preliminary revenue of $228 million to $231 million for the third quarter.

  • [By Lisa Levin]

    Shares of DXP Enterprises Inc (NASDAQ: DXPE) got a boost, shooting up 22 percent to $40.27 after the company posted upbeat quarterly results.

    Nature's Sunshine Prod. (NASDAQ: NATR) shares were also up, gaining 28 percent to $11.35 as the company disclosed that it has received its direct selling license in China.

trading stocks online: Arcadia Biosciences, Inc.(RKDA)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2016 earnings report formid cap pet stock agricultural biotechnology Arcadia Biosciences (NASDAQ: RKDA) is scheduled for after the market closes onThursday (November 10th). Last Thursday, our Under the Radar Movers newsletter suggestedthe stockas a short/bearish trade, saying:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Movers newsletter suggested small cap agricultural biotechnology Arcadia Biosciences (NASDAQ: RKDA) as a short/bearish trade:

trading stocks online: Cliffs Natural Resources Inc.(CLF)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    U.S. Steel was trading up 8.1 percent, AK Steel 4.5 percent, Cliffs Natural Resources Inc (NYSE: CLF) 7.7 percent and Steel Dynamics, Inc. (NASDAQ: STLD) 5.4 percent at the time of publication.

  • [By Tyler Crowe]

    No matter how much a commodity company like Cliffs Natural Resources (NYSE:CLF) tries, its fate will almost exclusively be in the hands of commodity prices. In the case of this past quarter, Cliffs was dealt a tougher hand as iron ore prices declined again. That may be enough to get some investors to head for the hills, but there were also some very promising signs that the company is setting itself up for a better long-term future.

  • [By Dan Caplinger]

    The stock market rebounded sharply on Thursday, making up for losses earlier in the week. Major benchmarks were up around 1% following solid earnings performances from several key companies, and some optimism about the possible fate of Trump administration policy on issues like corporate tax reform also helped turn around negative sentiment from previous sessions. Strength in the labor market was also a positive, and individual stocks Select Comfort (NASDAQ:SCSS), SLM Corp. (NASDAQ:SLM), and Cliffs Natural Resources (NYSE:CLF) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Lisa Levin]

    Basic materials shares rose by 0.74 percent in the US market on Friday. Top gainers in the sector included AK Steel Holding Corporation (NYSE: AKS), Cliffs Natural Resources Inc (NYSE: CLF), and United States Steel Corporation (NYSE: X).

  • [By Matthew DiLallo]

    Shares of Cliffs Natural Resources (NYSE:CLF) rocketed on Thursday and were up more than 16% by 2:30 p.m. EST after the iron ore miner reported expectation-beating fourth-quarter results.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

trading stocks online: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

trading stocks online: Laboratory Corporation of America Holdings(LH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Laboratory Corp. of America Holdings (NYSE: LH) is estimated to report its quarterly earnings at $1.96 per share on revenue of $2.19 billion.

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

  • [By Monica Gerson]

    Analysts expect Laboratory Corp. of America Holdings (NYSE: LH) to report its quarterly earnings at $1.96 per share on revenue of $2.19 billion. Laboratory Corp shares rose 0.64 percent to close at $121.77 on Friday.

value stocks

The following slide deck was published by Cancer Genetics, Inc. in conjunction with this event.

131

Click to enlarge

Notes:

value stocks: Maxwell Technologies, Inc.(MXWL)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedgoing long on small cap energy storage and power delivery stock Maxwell Technologies (NASDAQ: MXWL):

  • [By Monica Gerson]

    Maxwell Technologies (NASDAQ: MXWL) surged 9.20% to $10.21. The volume of Maxwell Technologies shares traded was 325% higher than normal. Maxwell’s trailing-twelve-month revenue is $190.57 million.

  • [By Lisa Levin]

    Shares of Maxwell Technologies Inc. (NASDAQ: MXWL) were down 15 percent to $5.34. Maxwell reported amended terms for deal with Viex Capital and announced a proposed offering of $50 million convertible senior notes due 2022.

value stocks: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 23 percent to $21.92 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 16 percent to $20.43. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Todd Campbell]

    Portola Pharmaceuticals’ (NASDAQ:PTLA)could have two commercial-stage drugs on the market next year, but turning them into top-sellers will require a lot of money. Is Portola Pharmaceuticals’ balance sheet flush enough with cash to get its drugs across the finish line?

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 30 percent to $20.08 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 14 percent to $20.96. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

value stocks: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

value stocks: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Snap-on (SNA)

    Snap-on, which is more than 100 years old, provides hand and power tools for individuals and professionals, including auto-shop tools and auto diagnostic equipment.

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews Nick Pinchuk, CEO of Snap-on (SNA) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By John Divine]

    Snap-on Incorporated (SNA) is my choice for the Best Stocks for 2016 competition. At a market cap of $10 billion, I doubt it will double over the next year, as some of the smaller companies in this competition might be able to.

    That said, Snap-on, which manufactures and markets hand tools and diagnostic equipment, is a rock-solid company with an attractive valuation and impressive growth. It goes for 22 times earnings, pays a consistent and modest dividend, and has been around since 1920.

    As cars get more tech-heavy and complicated, newer tools and better diagnostics will be needed — and that’s SNA’s bread ‘n’ butter. 

value stocks: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.

10 best stocks

Streaming media company Roku will likely have an initial public offering before the end of the year, adding another public company to a crowded field. Rumors are Roku is worth about $1 billion

The Congressional Budget Office (CBO) reports that Trump will not be able to balance the U.S. budget for a decade based on the president’s current plans.

Online fantasy betting sites DraftKings and FanDuel will not merge as expected. Both have faced regulatory problems and rising marketing costs. It was assumed that the two very similarcompanies could save money by eliminatingduplicate costs

Honda Motor Co. Ltd. (NYSE: HMC) recalled 1.2 million Accord models. According to the AP:

Honda is recalling 1.2 million Accord midsize cars in the U.S. because a battery sensor can short out and potentially cause a fire.

The recall covers cars from the 2013 through 2016 model years. Honda says it has four reports of engine compartment fires due to the problem but no injuries. All the fires were in states where salt is used to clear roads in the winter.

10 best stocks: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By WWW.USATODAY.COM]

    That’s what happens when someone decides to give a gift card. It counts as a gift, but in most cases a Starbucks (NASDAQ: SBUX) card (which one in six Americans received in 2015) or any other gift card mostly says either “I don’t know you that well” or “I don’t care about you that much.”

  • [By Chris Lange]

    And Starbucks Corp. (NASDAQ: SBUX) will report its most recent quarterly results on Thursday. The consensus estimates call for $0.55 in EPS and $5.81 billion in revenue. Shares closed trading at $54.88 on Friday, in a 52-week range of $50.84 to $64.87. The consensus price target is $63.98.

  • [By WWW.THESTREET.COM]

    The Starbucks (SBUX) inside Trump Tower has seen traffic drop dramatically. The shop’s usual customers, deterred by the barricades, armed guards and bomb-sniffing dogs outside, are getting their caffeine fix elsewhere.

  • [By Shanthi Rexaline]

    Quoting a survey, UBS said in a note Friday Starbucks Corporation (NASDAQ: SBUX) is well positioned for continued U.S. market share gains. The firm also delved on growth at its channel development segment and Chinese opportunities.

  • [By Ben Levisohn]

    Look at Starbucks (SBUX). The pre-eminent purveyor of overprice coffee’s stock is soaring today…and I have don’t have much of an idea why.

    Agence France-Presse/Getty Images

    It’s not that Starbucks has actually been performing well this year. Before today, its stock had dropped 0.9% in 2017, well below the 6.9% total return in the S&P 500.

    But flying it is, and along with Darden Restaurants (DRI) and McDonald’s (MCD), Starbucks find itself among the top 25 performers in the S&P 500 today. So let’s acknowledge industry strength today, because that appears to be a big part of what’s happening here. In fact, Canaccord Genuity’s Lynne Collier and Philip May, in a casual dining update, argued that trends across the industry are getting better:

    Our restaurant checks for the first week of March suggest a second consecutive week of positive comps (LSD) for the casual diners. Once again, we believe the shift in the tax refund schedule is positively skewing results. While we project that the first week of the month was in positive territory, we are maintaining our March SSS estimate of -2.0% to 0.0% given inclement weather mid-month and an unfavorable Easter shift. While comps remain volatile m/m and it is difficult to discern underlying trends, we note that our March industry SSS estimate would represent an improvement vs. February, which was -3.4% according to Knapp Track.

    And while Starbucks didn’t release any data, or get upgraded by an analyst, it was on the receiving end of a positive comment from Wells Fargo’s Bonnie Herzog:

    We hosted an investor meeting atStarbucks’ HQ yesterday (3/16) with CFO Scott Maw and SVP-Store Development Andy Adams. Overall, we came away with greater conviction recent challenges are being appropriately addressed, and comps will reaccelerate in the back half of the year through higher ticket (premiumization and increased attach

  • [By Seth McNew]

    Some of what Chipotle is doing comes from Starbucks’ (NASDAQ:SBUX) playbook. The coffee company was a trailblazer in creating a digital and mobile strategy that has truly transformed the customer experience and added to Starbucks’ bottom line. Its app, which features a mobile wallet-style system of stored preferences and the ability to order ahead to pick up your drink without waiting in line, now has more than 13 million active users, and the company has pointed to its digital growth many times as a boost to its comparable-store sales and margin growth. Mobile payments now make up one-quarter of all Starbucks transactions.

10 best stocks: WashingtonFirst Bankshares Inc(WFBI)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of CASTLE CREEK CAPITAL PARTNERS IV, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=CASTLE+CREEK+CAPITAL+PARTNERS+IV%2C+LP

    These are the top 5 holdings of CASTLE CREEK CAPITAL PARTNERS IV, LPGuaranty Bancorp (GBNK) – 1,448,849 shares, 39.1% of the total portfolio. MBT Financial Corp (MBTF) – 1,876,423 shares, 23.6% of the total portfolio. WashingtonFirst Bankshares Inc (WFBI) – 489,377 shares, 15.19% of the total portfolio. Shares added by 4558.07%Eastern Virginia Bankshares Inc (EVBS) – 1,061,225 shares, 12.33% of the total portfolio. First NBC Bank Holding Co (FNBC) – 2,205,382 shares, 9.78% of the total portfolio. Added: Wa

10 best stocks: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares dropped 22 percent to $2.52 after the company reported results from the second FIT Phase 3 study for fostamatinib. The company disclosed that the study did not meet primary endpoint.

10 best stocks: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

10 best stocks: LG Display Co., Ltd.(LPL)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Corning Incorporated in a steady uptrend since we recommended the stock while Universal Display Corporation (NASDAQ: OLED) has taken off even higher and LG Display Co Ltd (NYSE: LPL) and AU Optronics Corp (NYSE: AUO) have given a similar performance:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    According to comments by Universal Display CEO Steve Abramson, Samsung (NASDAQOTH:SSNLF) is pouring $9 billion into building OLED production facilities this year. LG Display (NYSE:LPL) expects more than half of its 2020 revenues to come from OLED panels. The OLED TV market is expected to grow sixfold in the next four years, and the lighting panel market is only just getting started.

Top 5 Value Stocks To Buy For 2018

Small cap staffing stock Staffing 360 Solutions Inc (NASDAQ: STAF), which is in the midst of a global buy-and-build strategy through the acquisition of domestic and international staffing organizations with operations in the US and UK, hasannounced thatthe Company and its board of directors have rejected a recent buyout proposal for $1.10 per share by the Jackson Investment Group.The proposal by Jackson Investment Group was received by the Company on Thursday, March 23, 2017 and delivered to the Board on Friday, March 24, 2017.

Executive Chairman Brendan Flood commented:

“We truly appreciate the support of Jackson Investment Group and the words of confidence in our management team contained in the letter. However, we believe that the offer significantly undervalues the Company and would not be in the best interest of the Company and its shareholders.”

Top 5 Value Stocks To Buy For 2018: Polaris Industries Inc.(PII)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Supply could come from any number of industry players, including Winnebago Industries, Inc. (NYSE: WGO), Thor Industries, Inc. (NYSE: THO), Polaris Industries Inc. (NYSE: PII) and Camping World Holdings Inc (NYSE: CWH). However, whether it comes from existing inventory and whether suppliers can meet the demand are yet to be seen.

  • [By Steve Symington]

    Polaris Industries Inc.(NYSE:PII)announced first-quarter 2017 results on Tuesday morning, punctuated by a narrower-than-expected net loss, improving retail sales in North America, and stabilizing off-road vehicle (ORV) market share.

Top 5 Value Stocks To Buy For 2018: Fiat Chrysler Automobiles N.V.(FCAU)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Image a car company with sales off 19% through the first 11 months of the year. Imagine a car company that routinely ranks at or near the bottom of the evaluations of Consumer Reports, J.D. Power rankings and the American Customer Satisfaction Index. Imagine a car company that routinely has 100 days of vehicle in inventory, compared to an industry average near70. That company isFiat, the small car division of Fiat Chrysler Automobiles N.V. (NYSE: FCAU).

  • [By John Rosevear]

    The fifth-generation version of Honda’s well-regarded kid-hauler doesn’t look a whole lot different from the outgoing model, but it packs a slew of upgradesand some useful technology that Honda hopes will make it more competitive with fierce rivals from Toyota (NYSE:TM) and Fiat Chrysler Automobiles (NYSE:FCAU).

  • [By Paul Ausick]

    Of the Detroit Three, Fiat Chrysler Automobiles N.V. (NYSE: FCAU) increased its market share in the EU from 7.5% to 7.8% year over year, led by a 15.4% increase in sales of the company’s Fiat brand and a 44.5% jump in Alfa Romeo. Jeep brand sales dipped 7.2% year over year. FCA sold 107,950 units in May, up 11.5% compared with May 2016.

Top 5 Value Stocks To Buy For 2018: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

Top 5 Value Stocks To Buy For 2018: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Dan Moskowitz]

    Cott (NYSE: COT  ) produces and sells over 200 different types of beverages in over 50 countries, and it implements a highly effective strategy. Cott is what is known as a Fast Follower, which makes it unique to other beverage companies.

Top 5 Value Stocks To Buy For 2018: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston